CHA
PFE icon

Cedar Hill Associates’s Pfizer PFE Stock Holding History

Cedar Hill Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$338K Sell
8,170
-8,453
-51% -$351K 0.13% 84
2018
Q3 		$695K Sell
16,623
-14,912
-47% -$574K 0.16% 77
2018
Q2 		$1.08M Sell
31,535
-2,606
-8% -$89.1K 0.23% 74
2018
Q1 		$1.15M Sell
34,141
-127
-0.4% -$4.37K 0.23% 73
2017
Q4 		$1.18M Sell
34,268
-281
-0.8% -$9.58K 0.2% 74
2017
Q3 		$1.17M Buy
34,549
+22,760
+193% +$732K 0.2% 73
2017
Q2 		$376K Sell
11,789
-1,603
-12% -$50.6K 0.08% 68
2017
Q1 		$435K Hold
13,392
– – 0.09% 66
2016
Q4 		$413K Buy
13,392
+336
+3% +$10.3K 0.07% 66
2016
Q3 		$420K Sell
13,056
-632
-5% -$21.1K 0.07% 65
2016
Q2 		$457K Sell
13,688
-163
-1% -$5.2K 0.08% 64
2016
Q1 		$389K Hold
13,851
– – 0.07% 67
2015
Q4 		$424K Sell
13,851
-35
-0.3% -$1.1K 0.07% 67
2015
Q3 		$414K Buy
13,886
+198
+1% +$6.35K 0.07% 67
2015
Q2 		$435K Sell
13,688
-693
-5% -$22.6K 0.07% 68
2015
Q1 		$475K Sell
14,381
-193
-1% -$6.14K 0.08% 68
2014
Q4 		$431K Sell
14,574
-316
-2% -$9.06K 0.07% 72
2014
Q3 		$418K Sell
14,890
-716
-5% -$20.1K 0.07% 71
2014
Q2 		$439K Buy
15,606
+1,344
+9% +$38.3K 0.07% 68
2014
Q1 		$435K Sell
14,262
-580
-4% -$17.3K 0.07% 66
2013
Q4 		$431K Hold
14,842
– – 0.08% 67
2013
Q3 		$405K Sell
14,842
-858
-5% -$23.3K 0.08% 65
2013
Q2 		$417K Buy
+15,700
New +$434K 0.08% 68

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cedar Hill Associates's PFE Position: Q4 2018 in Review

Cedar Hill Associates reduced its Pfizer (PFE) stake by 51% in Q4 2018, selling an estimated $351K and leaving 8,170 shares worth $338K. The position accounts for 0.13% of the portfolio, ranked #84.

Cedar Hill Associates first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.18M in Q4 2017. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Cedar Hill Associates held 8,170 shares of Pfizer worth $338K as of Q4 2018.
  • Cedar Hill Associates sold 8,453 Pfizer shares in Q4 2018, an estimated $351K.
  • Pfizer made up 0.13% of Cedar Hill Associates's portfolio in Q4 2018, its #84 holding.
  • Cedar Hill Associates first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
  • Cedar Hill Associates's Pfizer position peaked at $1.18M in Q4 2017.
  • 2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Cedar Hill Associates's 13F filing for Q4 2018, filed 13 Feb 2019.